We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+8.39%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$7.35B
AUM Growth
-$124M
(-1.7%)
Cap. Flow
-$457M
Cap. Flow
% of AUM
-6.22%
Top 10 Holdings %
Top 10 Hldgs %
16.8%
Holding
945
New
203
Increased
182
Reduced
140
Closed
326
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$135M |
| 2 |
Keysight
KEYS
|
+$120M |
| 3 |
Baxter International
BAX
|
+$102M |
| 4 |
RTX Corp
RTX
|
+$96.1M |
| 5 |
Revolution Medicines
RVMD
|
+$73.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TE Connectivity
TEL
|
+$173M |
| 2 |
Teradyne
TER
|
+$107M |
| 3 |
Booking.com
BKNG
|
+$95.2M |
| 4 |
Electronic Arts
EA
|
+$85.2M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.2% |
| 2 | Technology | 26.7% |
| 3 | Industrials | 12.14% |
| 4 | Consumer Discretionary | 7.06% |
| 5 | Communication Services | 4.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Immatics
IMTX
$1.29B
| $6.75M | 0.09% |
+977,962
| New | +$8.01M |
|
252
Tyra Biosciences
TYRA
$1.61B
| $6.6M | 0.09% |
410,435
+111,419
| +37% | +$1.33M |
|
253
Kulicke & Soffa
KLIC
$4.74B
| $6.54M | 0.09% |
+124,192
| New | +$6.46M |
|
254
Amdocs
DOX
$6.28B
| $6.54M | 0.09% |
68,131
+61,405
| +913% | +$5.68M |
|
|
LATG
255
DELISTED
Chenghe Acquisition I Co. Class A Ordinary Shares
LATG
| $6.53M | 0.09% |
625,001
| – | – |
|
|
KVSC
256
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
| $6.45M | 0.09% |
635,700
| – | – |
|
257
Marvell Technology
MRVL
$189B
| $6.39M | 0.09% |
+147,660
| New | +$6.22M |
|
|
OTLY
258
Oatly Group
OTLY
$437M
| $6.37M | 0.09% |
131,634
+75,936
| +136% | +$3.55M |
|
259
Legend Biotech
LEGN
$3.73B
| $6.34M | 0.09% |
131,440
-7,527
| -5% | -$368K |
|
|
AZPN
260
DELISTED
Aspen Technology Inc
AZPN
| $6.34M | 0.09% |
27,685
+214
| +0.8% | +$44.4K |
|
261
Playtika
PLTK
$1.25B
| $6.23M | 0.08% |
+553,050
| New | +$5.55M |
|
262
Best Buy
BBY
$16.9B
| $6.18M | 0.08% |
78,936
-13,974
| -15% | -$1.15M |
|
263
International Flavors & Fragrances
IFF
$21.6B
| $6.03M | 0.08% |
+65,582
| New | +$6.52M |
|
264
Kura Oncology
KURA
$824M
| $5.99M | 0.08% |
+489,532
| New | +$6.11M |
|
265
Vor Biopharma
VOR
$1.28B
| $5.98M | 0.08% |
55,556
| – | – |
|
266
Xerox
XRX
$424M
| $5.95M | 0.08% |
+386,213
| New | +$6.24M |
|
|
INBX
267
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $5.93M | 0.08% |
+314,195
| New | +$7.31M |
|
268
Watsco Inc
WSO
$13.2B
| $5.9M | 0.08% |
+18,529
| New | +$5.44M |
|
269
Tenable Holdings
TENB
$3.98B
| $5.88M | 0.08% |
123,806
-45,237
| -27% | -$1.92M |
|
270
BioCryst Pharmaceuticals
BCRX
$2.36B
| $5.85M | 0.08% |
701,580
-1,369,403
| -66% | -$13.2M |
|
271
Regenxbio
RGNX
$722M
| $5.78M | 0.08% |
305,822
-214,813
| -41% | -$4.75M |
|
|
HAIA
272
DELISTED
Healthcare AI Acquisition Corp. Class A Ordinary Shares
HAIA
| $5.74M | 0.08% |
550,000
| – | – |
|
273
F5
FFIV
$23.5B
| $5.71M | 0.08% |
39,225
-125,659
| -76% | -$18.1M |
|
274
CONMED
CNMD
$1.49B
| $5.63M | 0.08% |
+54,192
| New | +$5.24M |
|
275
Innoviva
INVA
$1.56B
| $5.62M | 0.08% |
499,442
+251,849
| +102% | +$3.06M |
|
Similar funds
TCIIS
UIM
VAI
KK
Woodline Partners's Q1 2023 Portfolio in Review
As of Q1 2023, Woodline Partners held 945 positions worth $7.35B, down 1.7% from $7.47B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Woodline Partners withdrew a net $457M in Q1 2023, closing 326 positions and reducing 140 holdings. Its most notable exit was Electronic Arts, an estimated $85.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Industrials.
Against the trend, Woodline Partners opened a new position in Amphenol worth $139M.
- Woodline Partners's largest Q1 2023 buy was Amphenol: 3,410,252 shares worth $139M.
- Woodline Partners added most to Baxter International in Q1 2023, an estimated $102M increase.
- Woodline Partners's biggest Q1 2023 reduction was TE Connectivity, cutting an estimated $173M.
- Woodline Partners fully exited Electronic Arts in Q1 2023, selling an estimated $85.2M.
- Woodline Partners's ten largest holdings make up 17% of its $7.35B portfolio in Q1 2023.
- Woodline Partners opened 203 new positions and closed 326 in Q1 2023.
- Woodline Partners's portfolio value fell 1.7% quarter-over-quarter to $7.35B.
Based on Woodline Partners's 13F filing for Q1 2023, filed 15 May 2023.